" wait for a clear bottom, don't chase a falling knife. Add shares once a bottom has been established and either keep them or sell them into the next spike. But leave your core alone, even if you bought it high."
is just about exactly what I have been saying here---with one major, 1 minor exception. NEVER buy high---all this rot about, "miss the chance" "you'll be sorry if you don;t" etc is all coming from game boys.
If anyone likes this dog, trade into accumulation--which ti a total newbie may be out buy 1200 cheap, sell 1000 at a price that knocks the heck out the basis in the 200---then riinse and repeat. The beta on this dog lets anyone who refuses to drunk the koolade to get a poistion with a basis like that of insiders and cronies.
And SAYING that is what makes the koolade drinkers around here invent endless lies about me.
BY the way---you misquoted the trader's rule-- its "Don;t try to catch a falling knife."
And all that "exposed" and whatever is just part of the rats' droppings anyone who wants to learn this game needs to realise is a warning signal .
I'm smiling today... Evidently you want to become stupid and fall into being retail road kill by listening to the professional pumpers around here.\
Since, if memory serves, Jetpro is back to around break-even, having only suffered the 100% loss on "opportunity cost" (something I rarely count, but it does matter) against just putting his $ into S&P indexes, he may be smiling as well.
Free advice: Don;t fall for any of the ad hom rat's dropping spilled by the likes of msft, ips etc...Just notice they do it instead of using actual numbers to explain why this dog ought to price where it does.
Learn to play the phlipping game... If you don't, you'll get turned into road kill.
" On low volume, the MM can do whatever he/she wants." On any volume the robots do whatever they want to sucker in retail. THat is, you were far more right 10 years ago than now about low vol and manipulation.
I'm adding to the thumbs up on the basis that you are being rational. Those who call BTX a p&d are in fact wrong. What I have been saying, consistently, is that at almost any price it has ever traded it has been a chew toy for the specialists and MMs, and a cult favorite for a type of buy&hold--rather than any rational multiple of actual net revs it will ever have.
Therefore, those who like this dog, trade into accumulation, and don;t beleiove a word said by the so-called "longs" here with their "Monday is news day" $10 coming..." when blahb;lah is released...which is pure Statton-Oakmont smoke shop piffle.
Like how I am still waiting for any 100 rational words about how lo9ng it will take BTX to get $1000 net out of it so-called "Apple partnership."
" that this will be a very effective diagnostic," Yup... At some point. For it to be effective for the common stock, time to approval, acceptance and pricing has got to be part of the p=
Not stupid at all....as long as you are trading stock and not buying koolade.
Of you got it to burn, put it to work. I have had many a client take a flyer @ $2k a turn on intrguing tech plays--of which "biotech" is just a type.
Learn how to do the flippin due diligence, read filings, ignore smoke and hype, and then keep tuning and recycling those skills..."rinse and repeat" and you can make decent money playing this game.
Unless you are situated like Warren Buffet--trying to find places to put cash to work---trade into accumulation. Remember diversification. Learn how --as best you can at your level--hedge.
You are wondering because you are falling for the boiler room rhetoric. I check this board once a day, once my business day is over--which ranges from around 4pm to around 7--like today.
"Retreat ...tomorrow" ?? It correctly fairly well by close. Some major technical thing adjusted--as others are posting. Or--as has happened before on this dog--insiders and cronies are playing all the guys like you by trading info 2 days to two weeks before you find out about it.
Again--as example--I have never told you or anyone else not to buy this dog. I have said, that if you like it, trade into accumulation---roll with it. For a stone beginner l9ike you, that means somethi8ng like buying buying 1300 on a hard dip, selling 1000 when it gets pumped. Over and over.... and over. Until your basis is as near as possible to insiders and cronies.
The game boys who play this board want you to never do that---because then you'd be competing against them, and they need you to buy&hold forever.
I just want you to survive the learning process. Those who object to my posting want to feed off your carcass.
Take it as an example. Where is BTX mentioned on the Apple page for research hit? lololol.... Now---show any way for $1k gross to come to BTX from the apps.....
Then check how much BTX burned to get there.
Check each of those for how long between registering the C. Corp and starting the IPO. In the case of J&J it's 62 years. In the case of BTX it was barely 62 days.
Regeneron is also a good case, since if Mikey is right, it is going to get slaughtered by either BTX or ACTC....any day now.... really... any day now.... well..next week anyway....But the professional money shows no fear of that at all...
Thiumb up... On another hand, there were many who held that the price fully reflected Alibaba--with the rest of YHOO being "worth" functionally zero.
It also takes "ages" sometimes for the "no path to revenue over COG" to be reflected, but it does get there...see Twitter.
Well, here's an examp-le of classic Mikey double speak and lies: " These markers are the subject of multiple pending patent claims filed in numerous countries worldwide and are owned by OncoCyte." Nope. BTX owns any number of claims--none of which are proven--in numerous countries (duh...) as to whether the way BTX plays with the genes is original art, or someone else's art, or merely a property of nature.
THat's the trues thing you've said here. Learn to read filings, or get comfortable being retail road kill.
" Just hope it never goes low enough to be exercised. Or for warrants to be worthless. I went with warrants. I think that's enough time for the 7 subsidiaries to prove themselves and even see a spi" Wts can be exercised at ANY time up to expiry. There is no reason at all to exercise them unless the tape price is well above the strike price.
THat is, this is another case of BTX m"longs" being clueless while being played by insiders and cronies.
Thumbs up for making a case instead of peddling koolade or ranting some ad hom piffle. However, to me, the essence of the koolade rests in " products which are potentially transformative with good revenue streams." Transformative to health care outcomes" and "revenue leading to GAAP profits" is a pure leap of expectations vs reality.
As I have noted here from the time of announcement--as an example--BTX wants to compete in the breast cancer space with a generic equivalent of two approved ways to go. And the enterprise that developed one of them went belly up before positive revs.
As noted with the new gee-whiz Holy Science Kit, Batman "lifestyle app"--what's the gross revs to ne achieved? There's several $$million of BTX accumulated deficit to get the i/p to contribute. Now: what return? "TRanformative" in the marketplace--"Zilch" in the treasury--except as a way to place the next guaranteed $100mm in T-shares and death spiral debentures.
Reg FD: Once GERN dropped all the nonsense it sold to BTX, I out clients into it, trading into accumulation. When the successi9on plan was fully kicked in, clients' average basis was around 1 5/32, with 12% ROE on the capital put at risk.
" in which case what is the point of subsidiary?" It's a shell game with tax advantages for insiders and cronies. And it's precisely what Mikey announced was going to happen to BTX about 3 years ago..after some meetings with AK.
Thumbs up. Yeah-- i was using your proffered numbers. But pointing out that any effort to parse the present price of BTX is based on non-existent or demonstrably false cases for ongoing revenue. Nobody reads to hack their way through Graham to realise that an equity with no product but stock sales has an I/V of 0.
Thumbs up. Excellent question. By and large by "value" I mean I now know somebody's lying. As in, "A $39.95 value, now only $19.95. But wait--if you act now there's more." In equity analysis thr word can be used reasonably to mean "odds on sustainable, ongoing revenue stream." BTX's balance sheet leans heavily on its own estimate of the fungibility of the i/p. But wait--there's more... That AST i/p represented well over $165mm when it was on GERN's books, but cleared the mkt ~$6mm when it became BTX's.
As I have noted before CAT's p/b and p/s say something about being in the bulldozer and massive machine industry. Biotechs' reflect things about how little capex is involved in generating i/p that __becomes revenue streams__ --not "science" or "future" or blahblah... And sooner or later, any ticker reverts to the mean of such expected revs. In the case of BTX--as each and every new "long" here shows, that gets based on a lack of understanding of how these things work. The case by the scumsucking shorts is based on understanding how they do work.
Take the Icahn/app deal. Let's say 1mm people every year download a $5 app on which BTX gets 4-6% royalty. What's the revenue stream? And given the competition--how sustainable is the projection?
" so using the 70% ownership the per value of AST in BTX is 147/68 or $2.16. At 60% ownership it is 126/68 or $1.85" Quire right except fo0r one major mistake. You are confusing capitalisation with value. Since the __value__ of AST is less than $20mm, BTX is "overvalued" by 1 7/8 to 2 5/32.